Real‐World Survival Over 25 Years in Extensive‐Stage Small‐Cell Lung Cancer: The Impact of Immune Checkpoint Inhibitors
ABSTRACT Introduction Therapeutic progress for extensive‐stage small‐cell lung cancer (ES‐SCLC) has been limited. Although immune checkpoint inhibitors (ICIs) have been introduced, their real‐world impact on survival remains uncertain. We evaluated 25‐year survival trends and the association between...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2026-06-01
|
| Seri Bilgileri: | Thoracic Cancer |
| Konular: | |
| Online Erişim: | https://doi.org/10.1111/1759-7714.70316 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|